JOHN L. HIGGINS - 30 Jun 2021 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Chief Executive Officer, Director
Signature
By: Charles S. Berkman For: John L. Higgins
Issuer symbol
LGND
Transactions as of
30 Jun 2021
Transactions value $
$21,220
Form type
4
Filing time
02 Jul 2021, 17:14:09 UTC
Next filing
01 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Other $21.2K +247 +0.07% $85.91 338K 30 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).